Whenever possible, we need publicly funded trials for comparative effectiveness research, designed to evaluate similar drugs at comparable doses to determine their real comparative safety and efficacy. How else do we answer the question, “Is it really better?” Read more here. (Source: Robert Bohrer, HealthAffairs Blog, 2/20/15)